highly significantp =0.008
5 b), the vast majority (17 of the 20 (85%) women in the mifepristone group) exhibited a highly significant reduction in the luminal progenitor cell fraction regardless of BRCA mutation carrier state ( p =0.008; Fig. 5 e).
5 b), the vast majority (17 of the 20 (85%) women in the mifepristone group) exhibited a highly significant reduction in the luminal progenitor cell fraction regardless of BRCA mutation carrier state ( p =0.008; Fig. 5 e).